Deriving a dose and regimen for anti-glucosaminidase antibody passive-immunisation for patients with Staphylococcus aureus osteomyelitis
Staphylococcus aureus (S. aureus) osteomyelitis remains a major clinical problem. Anti-glucosaminidase (Gmd) antibodies (1C11) are efficacious in prophylactic and therapeutic murine models. Feasibility, safety and pharmacokinetics of 1C11 passive immunisation in sheep and endogenous anti-Gmd levels...
| 發表在: | European Cells & Materials |
|---|---|
| Main Authors: | , , , , , , , , , , , , , |
| 格式: | Article |
| 語言: | 英语 |
| 出版: |
Forum Multimedia Publishing LLC
2020-01-01
|
| 主題: | |
| 在線閱讀: | https://www.ecmjournal.org/papers/vol039/pdf/v039a06.pdf |
